New Atlas

Cargo ship at sunset

New piloting approach cuts cargo ship emissions by 17.3% in first trials

| By | -, Good News Links

Currently, most cargo ships go as quickly as they can from port A to port B. When they get there, they sit still and wait at idle, continuing to burn fuel, until it’s time for them to dock. The Blue Visby Solution simply tells the ships to slow down, so they arrive at port right on time. Pushing all that bulk through the water at a slower speed cuts down hugely on hydrodynamic drag, so the engines burn considerably less fuel.

New piloting approach cuts cargo ship emissions by 17.3% in first trials Read more

Vials of blood

Bacterial enzyme strips away blood types to create universal donor blood

| By | -, Good News Links

There’s a global shortage of blood supplies needed for life-saving transfusions due to factors that include an aging population with a higher demand for it and a lack of volunteer donors. To help address this challenge, researchers at the Technical University of Denmark (DTU) and Lund University, Sweden, have used enzymes produced by a common gut bacteria to remove the A and B antigens from red blood cells, bringing them one step closer to creating universal donor blood.

Bacterial enzyme strips away blood types to create universal donor blood Read more

Dog licking its snout

Cancer vaccine for dogs almost doubles survival rates in clinical trial

| By | -, Good News Links

Scientists at Yale University adapted existing human cancer treatments to find a new version that could benefit both humans and dogs. After conducting multiple clinical trials involving over 300 dogs over the past eight years, the researchers say that their canine cancer vaccine has almost doubled the 12-month survival rate for dogs with some types of cancer.

Cancer vaccine for dogs almost doubles survival rates in clinical trial Read more

Scientist holding new ultrathin pacemaker

Scientists invent ultrathin, wireless, light-operated pacemaker that cuts invasive surgery

| By | -, Good News Links

Scientists at the University of Chicago have developed a new pacemaker that’s thinner than a human hair, wireless, and operated entirely by light from an optic fiber. The non-invasive device could help regulate heart activity or even stimulate neurons in a set pattern to treat symptoms of conditions like Parkinson’s.

Scientists invent ultrathin, wireless, light-operated pacemaker that cuts invasive surgery Read more

3d illustration of gut and stomach pain

79% of Crohn’s disease patients in remission after early intervention

| By | -, Good News Links

Led by researchers from the University of Cambridge, a clinical trial examined the effectiveness of giving the immunotherapy drug infliximab earlier, as soon as possible after diagnosis. They employed what’s called a ‘top-down’ strategy, meaning the drug was given straight after diagnosis regardless of the patient’s symptom severity. They found that this early intervention significantly reduces complications of this often debilitating disease, including the need for surgery by a factor of 10.

79% of Crohn’s disease patients in remission after early intervention Read more

Solar panels

Turkish scientists develop “bumpy” solar panel concept that can harvest up to 66% more energy

| By | -, Good News Links

Solar cell efficiency may get a bump from bumps. New research from Turkey’s Abdullah Gül University suggests that building tiny domes into the surface of organic solar cells could boost their efficiency by up to two-thirds, while capturing light from a wider angle.

Turkish scientists develop “bumpy” solar panel concept that can harvest up to 66% more energy Read more

Aerial view of container ship

Decarbonization containers turn 78% of marine emissions into limestone in new pilot

| By | -, Good News Links

A remarkable pilot project installed on a 787-ft. container ship has proven it’s possible to capture emissions from the smokestacks of cargo ships with 78% efficiency and convert the CO2 into limestone pebbles, which can be offloaded and sold. London startup Seabound, funded by a US$1.5-million grant from the UK Government, partnered up with global shipping company Lomar to install the carbon capture equipment on one of its older and dirtier-burning ships, a medium-sized vessel capable of carrying more than 3,200 shipping containers.

Decarbonization containers turn 78% of marine emissions into limestone in new pilot Read more

Assortment of pills

Novel AI model rapidly determines if an antidepressant will work

| By | -, Good News Links

Amsterdam University Medical Center (UMC) and Radboud UMC researchers have developed an algorithm that, based on patient MRI scans and other data, can determine within a week if a particular antidepressant will, offering faster relief and minimizing often painful and damaging side effects. “This is important news for patients,” said Liesbeth Reneman, Professor of Neuroradiology at Amsterdam UMC. “Normally, it takes six to eight weeks before it is known whether an antidepressant will work.”

Novel AI model rapidly determines if an antidepressant will work Read more

Depiction of nerve cells

Researchers discover an effective non-opioid treatment for nerve pain

| By | -, Good News Links

Many available pain medications aren’t effective in reducing this often-debilitating type of chronic pain. However, researchers at the University of Texas at Austin (UT Austin), in collaboration with UT Dallas and the University of Miami, may have advanced the treatment of neuropathic pain by discovering a molecule that reduces mechanical hypersensitivity in mice.

Researchers discover an effective non-opioid treatment for nerve pain Read more

Person receiving nasal spray

Novel nasal COVID-19 vaccine offers longer, better immunity than jabs

| By | -, Good News Links

Researchers at Duke-NUS Medical School in Singapore have developed an intranasal COVID-19 vaccine that enhances the immune system’s response to the virus, providing longer-lasting, greater protection than vaccine injections, even against new and emerging variants. The novel vaccine candidate could mean fewer boosters in future.

Novel nasal COVID-19 vaccine offers longer, better immunity than jabs Read more

Start typing and press enter to search